| scholarly article | Q13442814 |
| P2093 | author name string | Grzegorz Bulaj | |
| H Steve White | |||
| Misty D Smith | |||
| Hee-Kyoung Lee | |||
| Liuyin Zhang | |||
| P2860 | cites work | Neurotensin and neurotensin receptors | Q28138527 |
| Contulakin-G, an O-glycosylated invertebrate neurotensin | Q28375469 | ||
| In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues | Q31155856 | ||
| In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors | Q31970611 | ||
| Enhancement of therapeutic protein in vivo activities through glycoengineering | Q34180647 | ||
| Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence | Q34245314 | ||
| Glycosylated neuropeptides: a new vista for neuropsychopharmacology? | Q34439678 | ||
| Neurotensin and pain modulation | Q36547980 | ||
| Bioactive analogs of neurotensin: focus on CNS effects | Q36553978 | ||
| Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin | Q39109781 | ||
| Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier | Q39322793 | ||
| Functional and pharmacological aspects of central neuropeptidergic transmission mediated by neurotensin and neuromedin n. | Q41764021 | ||
| Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation | Q43803817 | ||
| Synthesis and biological studies of novel neurotensin(8-13) mimetics | Q44203198 | ||
| Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides | Q44345606 | ||
| Evaluation of lactam-bridged neurotensin analogues adjusting psi(Pro10) close to the experimentally derived bioactive conformation of NT(8-13). | Q45104947 | ||
| An assessment of the antinociceptive efficacy of intrathecal and epidural contulakin-G in rats and dogs | Q45210748 | ||
| In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier | Q45274136 | ||
| Synthesis and biological activities of psi (CH2NH) pseudopeptide analogues of the C-terminal hexapeptide of neurotensin. | Q46211646 | ||
| Synthesis and biological activity of the mono- and di-galactosyl-vespulakinin 1 analogues | Q46410956 | ||
| Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels | Q46704914 | ||
| Peptide backbone modifications on the C-terminal hexapeptide of neurotensin | Q46752813 | ||
| Regional brain concentrations of neurotensin following amygdaloid kindled and cortical suprathreshold stimulation-induced seizures in the rat | Q48114049 | ||
| In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier | Q48148694 | ||
| [3H]neurotensin(8-13) binds in human brain to the same sites as does [3H]neurotensin but with higher affinity | Q48166694 | ||
| Kainic acid induced seizures: changes in somatostatin, substance P and neurotensin | Q48364227 | ||
| Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem | Q48670799 | ||
| Vespulakinins: new carbohydrate-containing bradykinin derivatives | Q52440345 | ||
| Improved bioavailability to the brain of glycosylated Met-enkephalin analogs | Q56114253 | ||
| Neurotensin-induced hypothermia: evidence for an interaction with dopaminergic systems and the hypothalamic--pituitary--thyroid axis | Q70529274 | ||
| Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analogues | Q72430534 | ||
| Neurotensin binding to extraneural and neural receptors: comparison with biological activity and structure--activity relationships | Q72863333 | ||
| Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues | Q73022471 | ||
| Synthesis and human neurotensin receptor binding activities of neurotensin(8-13) analogues containing position 8 alpha-azido-N-alkylated derivatives of ornithine, lysine, and homolysine | Q73223503 | ||
| Chemical synthesis and receptor binding of catfish somatostatin: a disulfide-bridged beta-D-Galp-(1-->3)-alpha-D-GalpNAc O-glycopeptide | Q73431351 | ||
| Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol | Q73455068 | ||
| Highly potent neurotensin analog that causes hypothermia and antinociception | Q73525799 | ||
| Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities | Q73613784 | ||
| Dermorphin and deltorphin glycosylated analogues: synthesis and antinociceptive activity after systemic administration | Q78162538 | ||
| P433 | issue | 3 | |
| P921 | main subject | glycosylation | Q898365 |
| P304 | page(s) | 400-405 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | ChemMedChem | Q2962252 |
| P1476 | title | Glycosylated neurotensin analogues exhibit sub-picomolar anticonvulsant potency in a pharmacoresistant model of epilepsy | |
| P478 | volume | 4 |
| Q35066670 | A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties |
| Q38028949 | Analgesic neuropeptide W suppresses seizures in the brain revealed by rational repositioning and peptide engineering |
| Q35174495 | Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010. |
| Q37845684 | Anticonvulsant neuropeptides as drug leads for neurological diseases |
| Q52094879 | Disease-Modifying Effects of Neural Regeneration Peptide 2945 in the GAERS Model of Absence Epilepsy. |
| Q42211085 | Familial 5q12.3 Microdeletion: Evidence for a Locus Associated with Epilepsy. |
| Q42964771 | Introduction of lipidization-cationization motifs affords systemically bioavailable neuropeptide Y and neurotensin analogs with anticonvulsant activities |
| Q27315088 | Knockdown of Carboxypeptidase A6 in Zebrafish Larvae Reduces Response to Seizure-Inducing Drugs and Causes Changes in the Level of mRNAs Encoding Signaling Molecules |
| Q34413859 | Neuropeptides as targets for the development of anticonvulsant drugs. |
| Q24647835 | Synthesis and applications of polyamine amino acid residues: improving the bioactivity of an analgesic neuropeptide, neurotensin |
Search more.